Schedule 13D ownership disclosure
TRANSLATE BIO INC
Security class unavailable · CUSIP: 89374L104
Event date: 2019-04-18
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,197,912
- Percent of class
- 7.0600%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000903423-19-000209
- Form type
- SC 13D
- Filer
- GSK plc
- CIK
- CIK 1131399
- Filed
- May 03, 2019
- Reporting period
- Apr 18, 2019
- Description
- Schedule 13D beneficial ownership